当前位置：
X-MOL 学术
›
Bioconjugate Chem.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Surface Biomodification of Liposomes and Polymersomes for Efficient Targeted Drug Delivery
Bioconjugate Chemistry ( IF 4.0 ) Pub Date : 2021-07-20 , DOI: 10.1021/acs.bioconjchem.1c00285 Hichem Moulahoum 1 , Faezeh Ghorbanizamani 1 , Figen Zihnioglu 1 , Suna Timur 1, 2
Bioconjugate Chemistry ( IF 4.0 ) Pub Date : 2021-07-20 , DOI: 10.1021/acs.bioconjchem.1c00285 Hichem Moulahoum 1 , Faezeh Ghorbanizamani 1 , Figen Zihnioglu 1 , Suna Timur 1, 2
Affiliation
|
Chemotherapy has seen great progress in the development of performant treatment strategies. Nanovesicles such as liposomes and polymersomes demonstrated great potential in cancer therapy. However, these nanocarriers deliver their content passively, which faces a lot of constraints during blood circulation. The main challenge resides in degradation and random delivery to normal tissues. Hence, targeting drug delivery using specific molecules (such as antibodies) grafted over the surface of these nanocarriers came as the answer to overcome many problems faced before. The advantage of using antibodies is their antigen/antibody recognition, which provides a high level of specificity to reach treatment targets. This review discusses the many techniques of nanocarrier functionalization with antibodies. The aim is to recognize the various approaches by describing their advantages and deficiencies to create the most suitable drug delivery platform. Some methods are more suitable for other applications rather than drug delivery, which can explain the low success of some proposed targeted nanocarriers. In here, a critical analysis of how every method could impact the recognition and targeting capacity of some nanocarriers (liposomes and polymersomes) is discussed to make future research more impactful and advance the field of biomedicine further.
中文翻译：
脂质体和聚合物体的表面生物修饰以实现有效的靶向药物递送
化疗在开发高效治疗策略方面取得了巨大进步。脂质体和聚合物囊泡等纳米囊泡在癌症治疗中显示出巨大的潜力。然而，这些纳米载体被动地传递其内容，这在血液循环过程中面临很多限制。主要挑战在于降解和随机递送到正常组织。因此，使用嫁接在这些纳米载体表面上的特定分子（如抗体）靶向药物递送成为克服以前面临的许多问题的答案。使用抗体的优势在于它们的抗原/抗体识别，这为达到治疗目标提供了高度的特异性。本综述讨论了使用抗体进行纳米载体功能化的许多技术。目的是通过描述各种方法的优缺点来识别它们，以创建最合适的给药平台。一些方法更适合其他应用而不是药物递送，这可以解释一些提出的靶向纳米载体的低成功率。在这里，讨论了每种方法如何影响某些纳米载体（脂质体和聚合物体）的识别和靶向能力的批判性分析，以使未来的研究更具影响力并进一步推动生物医学领域的发展。
更新日期：2021-08-19
中文翻译：
脂质体和聚合物体的表面生物修饰以实现有效的靶向药物递送
化疗在开发高效治疗策略方面取得了巨大进步。脂质体和聚合物囊泡等纳米囊泡在癌症治疗中显示出巨大的潜力。然而，这些纳米载体被动地传递其内容，这在血液循环过程中面临很多限制。主要挑战在于降解和随机递送到正常组织。因此，使用嫁接在这些纳米载体表面上的特定分子（如抗体）靶向药物递送成为克服以前面临的许多问题的答案。使用抗体的优势在于它们的抗原/抗体识别，这为达到治疗目标提供了高度的特异性。本综述讨论了使用抗体进行纳米载体功能化的许多技术。目的是通过描述各种方法的优缺点来识别它们，以创建最合适的给药平台。一些方法更适合其他应用而不是药物递送，这可以解释一些提出的靶向纳米载体的低成功率。在这里，讨论了每种方法如何影响某些纳米载体（脂质体和聚合物体）的识别和靶向能力的批判性分析，以使未来的研究更具影响力并进一步推动生物医学领域的发展。
京公网安备 11010802027423号